Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Rev. méd. Panamá ; 23(1): 14-16, Jan.-May 1998.
Article in Spanish | LILACS | ID: lil-409828

ABSTRACT

It is presented the experience with 90 patients receiving Eritropoietin s.c. and oral iron who were in chronic haemodialysis. After basic laboratories, including iron kinetic, in all of them was stopped oral iron and started i.v. iron 60 mgs per week, but keeping the same eritropoietin doses. The results showed an increased haemoglobin level from 6.5 to 11 g/dl mean values and a decreased doses of eritropoietin between 25 to 50%. This represent an important elevation of haemoglobin levels at a significant low cost


Subject(s)
Humans , Adolescent , Adult , Middle Aged , Anemia, Iron-Deficiency , Erythropoietin/administration & dosage , Erythropoietin/economics , Iron/administration & dosage , Hemoglobins/analysis , Hemoglobins/economics , Renal Insufficiency, Chronic/complications , Costs and Cost Analysis , Chronic Disease , Injections, Intravenous
2.
Rev. méd. Panamá ; 21(1/2): 55-59, Jan.-May 1996.
Article in Spanish | LILACS | ID: lil-409923

ABSTRACT

Erythropoietin (EP) injected subcutaneously (SC) 2 or 3 times a week, respectively, or intravenously (IV) 3 times a week, increased the hemoglobin and the hematocrit of all the patients so treated. The total units of EP used was less when it was administered SC. EP once or twice a week, respectively, administered SC also increased the hemoglobin and hematocrit in each case, and the total amount of EP used was also less


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Anemia/therapy , Renal Dialysis/adverse effects , Erythropoietin/administration & dosage , Renal Insufficiency, Chronic/blood , Anemia/blood , Anemia/etiology , Drug Administration Schedule , Hematocrit , Hemoglobin A , Renal Insufficiency, Chronic/therapy , Injections, Intravenous
3.
Rev. méd. Panamá ; 20(3): 116-123, Sept. 1995.
Article in Spanish | LILACS | ID: lil-409931

ABSTRACT

The authors determined the frequency of genes and haplotypes of the HLA system in 965 panamanian men and women not related to each other, between 6 and 65 years of age. The HLA-A locus genes with the highest frequency (f) were A2, with f 0.1763; A24, f 0.1584; A30, f 0.1340; A23, f 0.1069; A3, f 0.0774. The other 20 genes each had less than 0.07. The genes with the highest frequency for locus HLA-B were B35, f 0.1946; B44, f 0.0904; B7, f 0.0774; B60 and B61, f 0.0582. For locus HLA-C, the most frequent genes were Cw3 with f 0.1549 and Cw4, f 0.1444. For locus HLA-DR, the most frequent genes were DR2 with f 0.1283; DR3, f 0.0620; DR7, f 0.0409. The most frequent haplotypes in the panamanian population were A2-B35 with f 0.0382; A3-B35, f 0.0191; A24-35, f 0.0287; A24-B61, f 0.0239; A29-B44, f 0.0287; A30-B42, f 0.0239; A23-B44, f 0.0191; A1-B8, f 0.0143. The authors conclude that the panamanian population exhibits a high degree of polymorphism for loci HLA-A, B and C, while for locu HLA-DR the frequency is the median when compared with that in caucasian, negro and oriental groups; and that, according to locus, predominant genes originating from these groups and found, corroborating the multiracial origen of the panamanian population


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , HLA Antigens/genetics , Gene Frequency , Haplotypes , HLA-A Antigens/genetics , HLA-B Antigens/genetics , Panama , Histocompatibility Testing
SELECTION OF CITATIONS
SEARCH DETAIL